<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00543036</url>
  </required_header>
  <id_info>
    <org_study_id>SH 30107</org_study_id>
    <nct_id>NCT00543036</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shalvata Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shalvata Mental Health Center</source>
  <brief_summary>
    <textblock>
      Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week
      treatment trial for cannabis addiction as assessed by measures of drug intake and craving.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <condition>Marijuana Abuse</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>H-Coil deep TMS</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis
             abuse and are motivated to quit cannabis use as assessed in the screening visit and
             gave their written informed consent to participate in the study.

        Exclusion Criteria:

          -  History of a primary major psychiatric other then cannabis abuse, or cognitive
             disorder according to DSM-IV TR criteria.

          -  Hamilton depression scale rated 25 and above (moderate to severe depression)

          -  Current alcohol or other substance abuse or dependence

          -  Alcohol or other substance abuse or dependence during the last 12 months before
             recruitment.

          -  History of or evidence of significant brain malformation,neoplasm, head injury,
             cerebral vascular events,neurodegenerative disorder or brain surgery.

          -  Severe somatic co-morbidity

          -  History of seizures Cardiac pace maker or other electronic implants Pregnancy and
             lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziv Carmel, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abraham Zangen, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weizmann Institute, Rehovot, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ziv Carmel, M.D.</last_name>
    <phone>+972-9-7478570</phone>
    <email>zivca@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shalvata Mental Health Center</name>
      <address>
        <city>Hod-HaSharon</city>
        <zip>45100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ziv Carmel, M.D</last_name>
      <phone>+972-9-7478570</phone>
      <email>zivca@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Ziv Carmel, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2007</study_first_submitted>
  <study_first_submitted_qc>October 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2007</study_first_posted>
  <last_update_submitted>October 11, 2007</last_update_submitted>
  <last_update_submitted_qc>October 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2007</last_update_posted>
  <keyword>Cannabis</keyword>
  <keyword>Addiction</keyword>
  <keyword>Craving</keyword>
  <keyword>TMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

